Canaccord Starts Seaport Therapeutics (SPTX) at Buy

October 14, 2026 5:14 AM

Canaccord analyst Sumant Kulkarni initiates coverage on Seaport Therapeutics (NASDAQ ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found